A short and efficient enantioselective synthesis of (R)-(−)-baclofen, a selective GABAB agonist has been described with an overall yield of 26% and 90% ee. Ru (II)–(S)-BINAP catalyzed asymmetric hydrogenations of C C and C O groups constitute the key steps in introducing stereogenic centers into the molecule.
